Somavert Subcutaneous Injection 15mg, manufactured by Pfizer, contains Pegvisomant (genetical recombination). This growth hormone receptor antagonist is used to treat acromegaly by blocking the effects of growth hormone. It has a YJ code of 2499409D2029 and a standard of 15 mg/bottle (with dissolving liquid).
Somavert Subcutaneous Injection 15mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →